Drug General Information
Drug ID	D0G7MM
Former ID	DIB008294
Drug Name	TA-8995
Synonyms	CETP inhibitor (dyslipidemia), Mitsubishi Tanabe
Indication	Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78]		Phase 2	[524491]
Company	Mitsubishi Tanabe Pharma Corp
Structure		Download 2D MOL
Target and Pathway
Target(s)	Cholesteryl ester transfer protein	Target Info	Inhibitor	[550249]
PANTHER Pathway	CCKR signaling map ST
Reactome	LDL-mediated lipid transport
	HDL-mediated lipid transport
WikiPathways	Statin Pathway
	Lipid digestion, mobilization, and transport
References
Ref 524491	ClinicalTrials.gov (NCT01970215) TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP). U.S. National Institutes of Health.
Ref 550249	Amgen To Acquire Privately-Held Dezima Pharma

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.